| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |